Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

CompletedOBSERVATIONAL

Enrollment

107,383

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

November 3, 2020

Study Completion Date

November 3, 2020

Conditions

Atrial FibrillationObesityAnticoagulants

Interventions

DRUG

Apixaban

Anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation.

Trial Locations (1)

Pfizer, New York